Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Carbidopa; levodopa - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for carbidopa; levodopa and what is the scope of carbidopa; levodopa patent protection?

Carbidopa; levodopa
is the generic ingredient in seven branded drugs marketed by Mayne Pharma, Impax Labs Inc, Apotex, Apotex Inc, Idt Australia Ltd, Impax Labs, Accord Hlthcare, Mylan, Sun Pharm Inds, Ranbaxy, Abbvie Inc, Merck Sharp Dohme, Actavis Elizabeth, Kv Pharm, SCS, Watson Labs, Sun Pharma Global, and Ucb Inc, and is included in twenty-nine NDAs. There are nine patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Carbidopa; levodopa has thirty-three patent family members in thirteen countries.

There are eighteen drug master file entries for carbidopa; levodopa. Thirty suppliers are listed for this compound.

Summary for Generic Name: carbidopa; levodopa

Drug Master File Entries: see list18
Suppliers / Packagers: see list30
Clinical Trials: see list148
Therapeutic Class:Antiparkinson Agents
Drug Prices:see low prices
DailyMed Link:carbidopa; levodopa at DailyMed

Pharmacology for Ingredient: carbidopa; levodopa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs Inc
carbidopa; levodopa
CAPSULE, EXTENDED RELEASE;ORAL203312-001Jan 7, 2015RXYesNo9,089,608► SubscribeY ► Subscribe
Merck Sharp Dohme
carbidopa; levodopa
TABLET;ORAL017555-002Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
Impax Labs Inc
carbidopa; levodopa
CAPSULE, EXTENDED RELEASE;ORAL203312-003Jan 7, 2015RXYesNo7,094,427► SubscribeY ► Subscribe
carbidopa; levodopa
TABLET;ORAL074080-001Mar 25, 1994DISCNNoNo► Subscribe► Subscribe
Mayne Pharma
carbidopa; levodopa
TABLET;ORAL073618-001Aug 28, 1992ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus